ROME Therapeutics
Tomas Mustelin is the Professor of Medicine and Chief of Rheumatology at the University of Washington.
His current research is focused on elucidating the molecular underpinnings of rheumatoid arthritis, systemic lupus erythematosus, ANCA-associated vasculitis, primary Sjögren’s syndrome, and other autoimmune conditions. He is exploring the role of retrotransposons and endogenous retroviruses in the pathogenesis of these diseases. Professor Mustelin has more than 35 years of research experience, including 10 years as a senior executive in drug discovery and development in the biotech/pharma industry where he led the generation of over two dozen novel drug candidates. He has been a professor since 1999 and has published over 250 papers. Tomas earned MD and PhD degrees from the University of Helsinki, Finland. He was a post doc at Scripps Clinic in La Jolla, CA, is a Docent in Cell Biology at the University of Helsinki, and a licensed physician in the European Union.
This person is not in the org chart
This person is not in any offices
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”